Margaret Lunn-Halbert

7PUBLICATIONS
34CO-AUTHORS
HaematologyBiomolecular modelling and designApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active moleculesInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 01, 2026
Astatine 211-based conditioning with a humanized CD45 antibody for autologous hematopoietic stem cell gene therapy.

|Nov 24, 2025
High-Throughput De Novo Protein Design Yields Novel Immunomodulatory Agonists.

Mohamad Abedi, Marc Expòsit, Brian Coventry

|Oct 26, 2024
Optimizing Siglec-8-Directed Immunotherapy for Eosinophilic and Mast Cell Disorders.

Sheryl Y T Lim, Jenny Huo, George S Laszlo

|Mar 13, 2024
Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET® CC-96191.

Margaret C Lunn-Halbert, George S Laszlo, Sarah Erraiss

|Apr 27, 2022
Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies.

George S Laszlo, Johnnie J Orozco, Allie R Kehret

|Feb 16, 2021
Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy.

Colin D Godwin, George S Laszlo, Salvatore Fiorenza

Pageof 2

Frequent Collaborators

6 joint publications

Roland B Walter

3 joint publications

Allie R Kehret

3 joint publications

Sheryl Y T Lim

2 joint publications

Hans-Peter Kiem